Organisation paid for research Program year 2025 Source: CMS Open Payments

Wake Forest Univ Hlth Sciences

Neither a doctor nor a teaching hospital

Research payments

$568,338

89 payments

Through program year 2025, Wake Forest Univ Hlth Sciences is reported as receiving $568,338 in research payments, across 89 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$11,035	2
2024	Research	$223,201	17
2023	Research	$214,027	14
2022	Research	$24,043	29
2021	Research	$2,452	5
2020	Research	$28,746	4
2019	Research	$64,835	18

Breakdown

Who paid Research payments · program years 2019–2025

CSL Behring $370,905 67 payments
Amgen Inc. $135,291 5 payments
Boehringer Ingelheim International GmbH $49,300 11 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $8,156 3 payments
Pfizer Inc. $4,687 3 payments

Studies the money was for Research payments · program years 2019–2025

A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra / Beriplex]) to Improve Survival in Patients With Traumatic Injury and Acute Major Bleeding $302,736 21 payments
20170625_Vesalius - CV $103,667 1 payment
Empa-Kidney $49,300 11 payments
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome $48,093 11 payments
Vesalius - CV $27,840 1 payment
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients $20,075 35 payments
DCRI Registry Study $8,156 3 payments
Strive A Multicenter Phase 2 Randomized Doubleblind Efficacy and Safety Study of Enzalutamide VS Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy $4,687 3 payments
Galactic-Hf $2,638 1 payment
AMG 199 20180290 Container. $683 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.